ASCO 2025: vídeos e entrevistas
85 vídeos do ASCO 2025 publicados por ASCO, ASCO Podcasts, OncLive, Oncology Brothers, Targeted Oncology, ecancer. Atualizado em 20/11/2026.
Managing Immune-Related Toxicities in OncologyASCO Podcasts · 06/11/2025 · 14:59
A Podcast About Podcasts: Podcasts as Educational Tools for Providers (and Patients)ASCO Podcasts · 21/10/2025 · 23:15
IMforte - Maintenance Lurbinectedin + Atezo FDA Approval for Extensive Small Cell Lung Cancer (SCLC)Oncology Brothers · 06/10/2025 · 25:31 · apoio da indústria
Managing Side Effects of New Treatments for Small Cell Lung CancerOncology Brothers · 29/08/2025 · 14:57 · apoio da indústria
Key insights from lung cancer research at ASCO 2025ecancer · 28/08/2025 · 15:32 · apoio da indústria
Key insights from head and neck research at ASCO 2025ecancer · 28/08/2025 · 14:20 · apoio da indústria
Catequentinib improves PFS vs placebo in advanced or metastatic leiomyosarcomaecancer · 28/08/2025 · 3:01 · apoio da indústria
AI improves accuracy in identifying HER2-low and HER2-ultralow breast cancersecancer · 28/08/2025 · 5:54 · apoio da indústria
Primary cytoreductive surgery shows PFS benefit in advanced ovarian cancerecancer · 28/08/2025 · 3:58 · apoio da indústria
HPK1 inhibitor NDI-101150 shows safety and antitumour activity in ccRCCecancer · 28/08/2025 · 2:38 · apoio da indústria
ctDNA-guided chemo escalation does not improve recurrence-free survival in stage III colon cancerecancer · 28/08/2025 · 5:26 · apoio da indústria
ASCO 2025: Breast cancer treatment highlightsecancer · 28/08/2025 · 4:36 · apoio da indústria
QoL maintained with sasanlimab plus BCG in high-risk, BCG-naive NMIBCecancer · 28/08/2025 · 5:39 · apoio da indústria
Long-term infusion of dinutuximab beta improves survival in high-risk neuroblastomaecancer · 28/08/2025 · 6:27 · apoio da indústria
Upfront modified FOLFOXIRI plus panitumumab improves OS in RAS/BRAF wild-type mCRCecancer · 28/08/2025 · 2:15 · apoio da indústria
Ropeginterferon Alfa-2b shows superior efficacy and safety over anagrelide in essential thromboc...ecancer · 28/08/2025 · 3:56 · apoio da indústria
Nivolumab plus ipilimumab vs gemcitabine-carboplatin in cisplatin-ineligible metastatic urotheli...ecancer · 28/08/2025 · 4:01 · apoio da indústria
Molecular assay may help identify NSCLC patients who could benefit from adjuvant chemotherapyecancer · 28/08/2025 · 2:56 · apoio da indústria
Rusfertide shows promise for polycythemia vera treatmentecancer · 28/08/2025 · 4:05 · apoio da indústria
GLP-1 receptor agonists may slightly reduce risk of fourteen obesity-related cancers for diabeticsecancer · 28/08/2025 · 2:41 · apoio da indústria
OS benefit for Tumor Treating Fields plus chemo in unresectable pancreatic cancerecancer · 28/08/2025 · 3:27 · apoio da indústria
Encorafenib/binimetinib/nivolumab combo improves PFS in BRAF-mutant melanoma brain metastasesecancer · 28/08/2025 · 3:46 · apoio da indústria
HER2-positive breast cancer: Predicting pCR from clinicopathologic variables and genomic testingecancer · 28/08/2025 · 7:05 · apoio da indústria
Trastuzumab deruxtecan benefit for some advanced gastric cancersecancer · 28/08/2025 · 3:23 · apoio da indústria
QoL improvements ID'd in phase 3 ARANOTE trial for mHSPCecancer · 28/08/2025 · 3:39 · apoio da indústria
Trastuzumab deruxtecan plus pertuzumab may delay cancer growth for some HER2-positive advanced b...ecancer · 28/08/2025 · 2:36 · apoio da indústria
Sacituzumab govitecan helps some patients with PD-L1 triple-negative breast cancer live longer w...ecancer · 28/08/2025 · 1:50 · apoio da indústria
ASCO 2025: Update on blood-based cancer assaysecancer · 28/08/2025 · 3:32 · apoio da indústria
Ecological evaluation of climate risks for cancer survivorsecancer · 28/08/2025 · 3:14 · apoio da indústria
Enhanced pathologic response with neoadjuvant pembrolizumab plus vidutolimod in high-risk resect...ecancer · 28/08/2025 · 3:31 · apoio da indústria
Study shows characteristics associated with longer-term overall survival with NALIRIFOX regimen ...ecancer · 28/08/2025 · 2:29 · apoio da indústria
Neoadjuvant gemcitabine and cisplatin improves OS in resectable biliary tract cancerecancer · 28/08/2025 · 3:50 · apoio da indústria
Cemiplimab reduces disease recurrence as adjuvant therapy for cutaneous squamous cell carcinomaecancer · 28/08/2025 · 4:27 · apoio da indústria
Relacorilant plus chemo improves PFS and OS vs chemo alone in platinum-resistant ovarian cancerecancer · 28/08/2025 · 3:32 · apoio da indústria
Perioperative durvalumab and FLOT chemo can reduce risk of recurrence for some gastric cancersecancer · 28/08/2025 · 5:52 · apoio da indústria
Abemaciclib potential therapeutic option for Kaposi sarcomaecancer · 28/08/2025 · 5:33 · apoio da indústria
BCG combined with mitomycin offers improved adjuvant treatment regimen for high-risk NMIBCecancer · 28/08/2025 · 4:07 · apoio da indústria
Pro-inflammatory diets associated with worse outcomes for stage III colon cancerecancer · 28/08/2025 · 2:30 · apoio da indústria
Barriers to global oncology clinical trial participation in sub-Saharan Africaecancer · 28/08/2025 · 4:52 · apoio da indústria
Making immune check point inhibitors for lung cancer cost-effective in LMICsecancer · 28/08/2025 · 5:37 · apoio da indústria
Social determinants and survival outcomes in early-onset colorectal cancer in the USecancer · 28/08/2025 · 5:49 · apoio da indústria
Oral paclitaxel shows non-inferior efficacy compared to IV paclitaxel for HER2-negative mBCecancer · 28/08/2025 · 4:39 · apoio da indústria
Low frequency of actionable dihydropyrimidine dehydrogenase variants in Mexicans with GI cancers...ecancer · 28/08/2025 · 3:30 · apoio da indústria
CtDNA useful biomarker for muscle-invasive bladder cancer patients who received perioperative du...ecancer · 28/08/2025 · 4:19 · apoio da indústria
Exercise programme may lower risk of recurrence and death for some colon cancer survivorsecancer · 28/08/2025 · 4:05 · apoio da indústria
Untangling ASCO 2025 Data in Oncology: Episode 4OncLive · 23/07/2025 · 7:16 · apoio da indústria
Untangling ASCO 2025 Data in Oncology: Episode 3OncLive · 16/07/2025 · 5:54 · apoio da indústria
Untangling ASCO 2025 Data in Oncology: Episode 2OncLive · 09/07/2025 · 9:09 · apoio da indústria
ASCO 2025 - GU Cancer Highlights: KEYNOTE-564, AMPLITUDE, ARANOTE, NIAGARAOncology Brothers · 04/07/2025 · 18:17 · apoio da indústria
Untangling ASCO 2025 Data in Oncology: Episode 1OncLive · 02/07/2025 · 6:12 · apoio da indústria
Immunotherapy at ASCO25: Drug Development, Melanoma Treatment, and MoreASCO Podcasts · 27/06/2025 · 27:02
Innovations in GU Cancer Treatment at ASCO25ASCO Podcasts · 26/06/2025 · 29:47
Dr Turk Delves Into CRC Updates From ASCO 2025Targeted Oncology · 26/06/2025 · 4:35 · apoio da indústria
What Lung Cancer Abstracts Stood Out at ASCO25?ASCO Podcasts · 25/06/2025 · 29:50
GI Cancer Research at ASCO25: Plenary Highlights and MoreASCO Podcasts · 24/06/2025 · 21:17
Breast Cancer Research Poised to Change Practice From ASCO25ASCO Podcasts · 23/06/2025 · 31:39
Precision Oncology Advances in Hematologic Cancers at ASCO25ASCO Podcasts · 20/06/2025 · 18:23
ASCO 2025 - Breast Cancer Highlights: INAVO120, SERENA-6, VERITAC-2, DESTINY-Breast09, ASCENT-04Oncology Brothers · 20/06/2025 · 22:29 · apoio da indústria
ASCO25 Recap: CHALLENGE, DESTINY-Breast09, and MoreASCO Podcasts · 19/06/2025 · 25:46
ASCO 2025: Expert Insights & Top Abstracts Across CancersTargeted Oncology · 19/06/2025 · 9:37 · apoio da indústria